Joshua Fitch, Senior Editor

Investigators sought to evaluate characteristics of adolescents with a history of depression who do not endorse risk via the PHQ item 9, which is commonly used to screen for self-harm and suicide risk.

Across all age groups, obesity rates increased during the pandemic and decreased in the post-pandemic period (P < 0.01).

A poster session evaluated early evidence from the randomized controlled iREACH trial.

A recap of the American College of Cardiology meeting and discussion of obesity and hypertension in the pediatric population.

The new data, published in The Lancet, showed that nirsevimab substantially reduced RSV hospitalizations.

A recent nationally representative survey revealed what types of meals parents believe are healthy for their children, and how much food is the healthy amount.

ICD-10 accuracy varied by age of the patient, influenza season definition, time between onset and testing, and clinical setting.

The resubmission was announced in a first quarter, 2024 earnings news release from Lilly, which expects "regulatory action in the second half of 2024."

Data from a recent study revealed that stigma associated with chronic skin diseases made an impact on the quality of life of affected children and adolescents.

A discussion based on an FDA-cleared objective ADHD diagnostic test developed by Qbtech.

The rare genetic disease causes the body's immune system to not function properly.

A decision from the federal agency is expected in the fourth quarter of 2024.

With the approval comes the immediate availability of 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg doses for patients between 2 to 5 years of age.

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Though concern exists about the associations of marijuana legalization and youth use, no links were found in a recent study.

Perry Roy, MD, explains how an FDA-cleared objective test can assist in an ADHD diagnosis.

This decision from the federal agency marks the first FDA approval of a systemic therapy to treat patients with pediatric LGG with BRAF rearrangements, including fusions.

The FDA has approved lutetium Lu 177 dotatate for pediatric patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors.

The biosimilar to ustekinumab is approved for patients 6 years and up, and is expected to be marketed on or after February 21, 2025.

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

A discussion of outpatient management and treatment of eating disorders in youth patients, plus the importance of a multidisciplinary team throughout the process.

The 5-in-1 vaccine candidate has the potential to reduce shots and simplify the immunization process.

“These findings suggest that primordial and primary interventions to prevent and reduce elevated childhood non–HDL-C levels may help prevent premature CVD," wrote the study authors.

The low-dose, coformulated regimen was well tolerated, and overall data supports its use in children with HIV aged 2 years and older weighing between 30.86 lbs (14 kg) and 55.11 lbs (25 kg).

The monoclonal antibody was approved by the FDA on July 17, 2023 and quickly saw high demand at the onset of the RSV season.

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Allison Scott, DNP, CPNP-PC, IBCLC, reviews the updated breastfeeding guidelines from the American Academy of Pediatrics.

Juanita Mora, MD, breaks down the FDA approval of benralizumab as an add-on maintenance therapy among patients with severe asthma aged 6 to 11 years.

April 10, 2024 is National Youth HIV & AIDS Awareness Day.

When deciding whether to keep their child home from school, 4% of parents contacted a health care provider for advice.